Výsledky vyhledávání

Akademický článek

Role of germinal center and CD39 ^high CD73 ⁺ B cells in the age-related tonsillar involution.

Autor: Pastor R; Institute of Immunology, Genetics and Metabolism (INIGEM), Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), National Council for Scientific and Technological Research (CONICET), Av Córdoba 2351, C1120AAF, Buenos Aires, CABA, Argentina.; Department of Biological Sciences, Faculty of Exact Sciences, Institute of Immunological and Physiopathological studies (IIFP), University of La Plata (UNLP), National Council for Scientific and Technological Research (CONICET), La Plata, Argentina., Puyssegur J; Institute of Immunology, Genetics and Metabolism (INIGEM), Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), National Council for Scientific and Technological Research (CONICET), Av Córdoba 2351, C1120AAF, Buenos Aires, CABA, Argentina., de la Guardia MP; Institute of Immunology, Genetics and Metabolism (INIGEM), Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), National Council for Scientific and Technological Research (CONICET), Av Córdoba 2351, C1120AAF, Buenos Aires, CABA, Argentina., Varón LS; Institute of Immunology, Genetics and Metabolism (INIGEM), Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), National Council for Scientific and Technological Research (CONICET), Av Córdoba 2351, C1120AAF, Buenos Aires, CABA, Argentina., Beccaglia G; Department of Pathology, Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), Buenos Aires, Argentina., Spada N; Department of Pathology, Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), Buenos Aires, Argentina., de Lima AP; Department of Pathology, Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), Buenos Aires, Argentina., Collado MS; Institute of Immunology, Genetics and Metabolism (INIGEM), Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), National Council for Scientific and Technological Research (CONICET), Av Córdoba 2351, C1120AAF, Buenos Aires, CABA, Argentina., Blanco A; Institute of Otolaryngology Arauz, Buenos Aires, Argentina., Scetti IA; Institute of Otolaryngology Arauz, Buenos Aires, Argentina., Arabolaza ME; Pediatric Otolaryngology Division, Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), Buenos Aires, Argentina., Paoli B; Pediatric Otolaryngology Division, Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), Buenos Aires, Argentina., Chirdo F; Department of Biological Sciences, Faculty of Exact Sciences, Institute of Immunological and Physiopathological studies (IIFP), University of La Plata (UNLP), National Council for Scientific and Technological Research (CONICET), La Plata, Argentina., Arana E; Institute of Immunology, Genetics and Metabolism (INIGEM), Clinical Hospital 'José de San Martín', University of Buenos Aires (UBA), National Council for Scientific and Technological Research (CONICET), Av Córdoba 2351, C1120AAF, Buenos Aires, CABA, Argentina. eloarana@yahoo.com.; Department of Immunology, School of Medicine, University of Buenos Aires (UBA), Buenos Aires, Argentina. eloarana@yahoo.com.

Publikováno v: Immunity & ageing : I & A [Immun Ageing] 2024 Apr 12; Vol. 21 (1), pp. 24. Date of Electronic Publication: 2024 Apr 12.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Report

Genomic and biochemical analysis of repeatedly observed variants in DBT in individuals with maple syrup urine disease of Central American ancestry.

Autor: Billington CJ Jr; Children's National Rare Disease Institute, Washington, District of Columbia, USA.; Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA., Chapman KA; Children's National Rare Disease Institute, Washington, District of Columbia, USA., Leon E; Children's National Rare Disease Institute, Washington, District of Columbia, USA., Meltzer BW; Laboratory Medicine, Children's National Hospital, Washington, District of Columbia, USA., Berger SI; Children's National Rare Disease Institute, Washington, District of Columbia, USA., Olson M; HemoShear Therapeutics, Inc., Charlottesville, Virginia, USA., Figler RA; HemoShear Therapeutics, Inc., Charlottesville, Virginia, USA., Hoang SA; HemoShear Therapeutics, Inc., Charlottesville, Virginia, USA., Wanxing C; Georgetown University Hospital, Washington, District of Columbia, USA., Wamhoff BR; HemoShear Therapeutics, Inc., Charlottesville, Virginia, USA., Collado MS; HemoShear Therapeutics, Inc., Charlottesville, Virginia, USA., Cusmano-Ozog K; Department of Pathology, Stanford University Medical Center, Stanford, California, USA.

Publikováno v: American journal of medical genetics. Part A [Am J Med Genet A] 2022 Sep; Vol. 188 (9), pp. 2738-2749. Date of Electronic Publication: 2022 Jul 07.

Zobrazit plný text záznamu

Akademický článek

A novel small molecule approach for the treatment of propionic and methylmalonic acidemias.

Autor: Armstrong AJ; HemoShear Therapeutics, Inc., Charlottesville, VA, USA., Collado MS; HemoShear Therapeutics, Inc., Charlottesville, VA, USA., Henke BR; HemoShear Therapeutics, Inc., Charlottesville, VA, USA., Olson MW; HemoShear Therapeutics, Inc., Charlottesville, VA, USA., Hoang SA; HemoShear Therapeutics, Inc., Charlottesville, VA, USA., Hamilton CA; HemoShear Therapeutics, Inc., Charlottesville, VA, USA., Pourtaheri TD; HemoShear Therapeutics, Inc., Charlottesville, VA, USA., Chapman KA; Children's National Rare Disease Institute, Washington, DC, USA., Summar MM; Children's National Rare Disease Institute, Washington, DC, USA., Johns BA; HemoShear Therapeutics, Inc., Charlottesville, VA, USA., Wamhoff BR; HemoShear Therapeutics, Inc., Charlottesville, VA, USA. Electronic address: wamhoff@hemoshear.com., Reardon JE; HemoShear Therapeutics, Inc., Charlottesville, VA, USA., Figler RA; HemoShear Therapeutics, Inc., Charlottesville, VA, USA.

Publikováno v: Molecular genetics and metabolism [Mol Genet Metab] 2021 May; Vol. 133 (1), pp. 71-82. Date of Electronic Publication: 2021 Mar 10.

Zobrazit plný text záznamu

Akademický článek

Identification of 2,2-Dimethylbutanoic Acid (HST5040), a Clinical Development Candidate for the Treatment of Propionic Acidemia and Methylmalonic Acidemia.

Autor: Armstrong AJ; HemoShear Therapeutics Inc., 501 Locust Avenue, Charlottesville, Virginia 22902, United States., Henke BR; HemoShear Therapeutics Inc., 501 Locust Avenue, Charlottesville, Virginia 22902, United States., Collado MS; HemoShear Therapeutics Inc., 501 Locust Avenue, Charlottesville, Virginia 22902, United States., Taylor JM; HemoShear Therapeutics Inc., 501 Locust Avenue, Charlottesville, Virginia 22902, United States., Pourtaheri TD; HemoShear Therapeutics Inc., 501 Locust Avenue, Charlottesville, Virginia 22902, United States., Dillberger JE; HemoShear Therapeutics Inc., 501 Locust Avenue, Charlottesville, Virginia 22902, United States., Roper TD; HemoShear Therapeutics Inc., 501 Locust Avenue, Charlottesville, Virginia 22902, United States., Wamhoff BR; HemoShear Therapeutics Inc., 501 Locust Avenue, Charlottesville, Virginia 22902, United States., Olson MW; HemoShear Therapeutics Inc., 501 Locust Avenue, Charlottesville, Virginia 22902, United States., Figler RA; HemoShear Therapeutics Inc., 501 Locust Avenue, Charlottesville, Virginia 22902, United States., Hoang SA; HemoShear Therapeutics Inc., 501 Locust Avenue, Charlottesville, Virginia 22902, United States., Reardon JE; HemoShear Therapeutics Inc., 501 Locust Avenue, Charlottesville, Virginia 22902, United States., Johns BA; HemoShear Therapeutics Inc., 501 Locust Avenue, Charlottesville, Virginia 22902, United States.

Publikováno v: Journal of medicinal chemistry [J Med Chem] 2021 Apr 22; Vol. 64 (8), pp. 5037-5048. Date of Electronic Publication: 2021 Apr 13.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání